IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 33 filers reported holding IBERE PHARMACEUTICALS in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,513,500 | +1.8% | 150,000 | 0.0% | 0.05% | +33.3% |
| Q3 2022 | $1,487,000 | +1.0% | 150,000 | 0.0% | 0.04% | +5.9% |
| Q2 2022 | $1,472,000 | 0.0% | 150,000 | 0.0% | 0.03% | +3.0% |
| Q1 2022 | $1,472,000 | +1.2% | 150,000 | 0.0% | 0.03% | -13.2% |
| Q4 2021 | $1,455,000 | +0.1% | 150,000 | 0.0% | 0.04% | -9.5% |
| Q3 2021 | $1,454,000 | +0.2% | 150,000 | 0.0% | 0.04% | -6.7% |
| Q2 2021 | $1,451,000 | – | 150,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integrity Capital Management (HK) Ltd | 38,428 | $3,000 | 4.69% |
| Knott David M Jr | 18,000 | $207,000 | 0.09% |
| Radcliffe Capital Management, L.P. | 150,000 | $1,472,000 | 0.03% |
| MARSHALL WACE, LLP | 224,997 | $2,207,000 | 0.01% |
| TEGEAN CAPITAL MANAGEMENT, LLC | 68,565 | $4,002 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 13,499 | $132,000 | 0.00% |
| Ayrton Capital LLC | 28,393 | $2,000 | 0.00% |
| COWEN AND COMPANY, LLC | 218,283 | $17,000 | 0.00% |
| Alpine Global Management, LLC | 61,425 | $5,000 | 0.00% |
| Lynwood Capital Management Inc. | 9,800 | $1,000 | 0.00% |